Newborn Screening for Pompe Disease: Summary of the Condition Review Workgroup Report Alex R. Kemper, MD, MPH, MS May 17, 2013

First Page		Document Content
Date: 2014-12-04 01:12:49 Glycogen storage disease type II Newborn screening Screening Enzyme replacement therapy Fabry disease Health Rare diseases Medicine		Newborn Screening for Pompe Disease: Summary of the Condition Review Workgroup Report Alex R. Kemper, MD, MPH, MS May 17, 2013 Add to Reading List Source URL: www.hrsa.gov Download Document from Source Website File Size: 1,20 MB Share Document on Facebook

	Migalastat and Enzyme Replacement Therapy Have Comparable Effects on Renal Function in Fabry Disease: Phase 3 Study Results Nicholls, K1*, Bichet, DG2, Giugliani, R3, Hughes, D4, Schiffmann, R5, Wilcox, W6, Skuban, N7, R DocID: 1tiPw - View Document
	The Journal of Rare Disorders CochraneCorner DocID: 19CDW - View Document
	7 November 2014 Dear Committee Re: Life Saving Drugs Programme Review Fabry Support Group of Australia Submission DocID: W87d - View Document
	Minimum Recommended Schedule of Assessments for MPS I Patients Initial Assessments Every 6 DocID: VV2Y - View Document
	Pancreatic enzyme replacement therapy DocID: V3Jk - View Document